BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,115.00
-45.00 (-1.42%)
At close: Jun 5, 2026

BioInfra Revenue

BioInfra had revenue of 5.50B KRW in the quarter ending March 31, 2026, with 1.08% growth. This brings the company's revenue in the last twelve months to 23.21B, down -4.31% year-over-year. In the year 2025, BioInfra had annual revenue of 23.15B, down -2.87%.

Revenue (ttm)
23.21B
Revenue Growth
-4.31%
P/S Ratio
0.65
Revenue / Employee
n/a
Employees
n/a
Market Cap
15.15B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202523.15B-685.20M-2.87%
Dec 31, 202423.83B-6.30B-20.90%
Dec 31, 202330.13B-5.30B-14.96%
Dec 31, 202235.43B4.87B15.94%
Dec 31, 202130.56B10.95B55.82%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
HLB bioStep73.96B
DreamCIS69.87B
C&R Research62.70B
DT&CRO CO.47.77B
WOOJUNG BIO40.30B
P&K Skin Research Center22.56B
Penetrium Bioscience9.74B
Curachem6.02B
Revenue Rankings